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ABSTRACT 
Pertussis, also known as Whooping Cough, is a contagious disease that affects children 
more than adults, especially children under the age of 12 months. In the United States in 
2009, there were more than 16,000 cases of pertussis in infants less than 6 month of 
age (National Network for Immunizations and Information, 2011). At a local Midwestern 
community hospital, a revised Tdap policy that consisted of an education component 
and standardization of when the vaccine was administered was implemented to increase 
the acceptance rate of Tdap vaccines among postpartum mothers due to their 
significantly low Tdap acceptance rate. The purpose of this project was to determine if 
implementation of a Tdap postpartum policy that includes a patient education 
component, and standardization of when the vaccine is given affects the Tdap vaccine 
acceptance rate among postpartum women, using the John Hopkins Nursing Evidence-
Based Practice Model to guide the study. A retrospective chart review was conducted 
three months prior to implementation of the Tdap practice change and the data were 
compared with the information collected three months post implementation of the 
project.  There was a significant difference in tdap acceptance rate among postpartum 
mothers, a chi squared statistical analysis was performed on the pre and post group to 
determine overall acceptance rate of the vaccine.  Documentation of patient education 
on the Tdap vaccine increased from 0 to 13.2% over the three month period. Revising 
the Tdap policy, standardization of the vaccine and educating the nurses and patients on 
the Tdap vaccine increased the overall Tdap acceptance among postpartum mothers. 
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CHAPTER 1 
INTRODUCTION 
Background 
Pertussis, also known as whooping cough, is a contagious disease that affects 
children more than adults, especially children under the age of 12 months. The disease 
has been around since the 16th century, but researchers and medical professionals had 
no idea what caused the disease (CDC, 2012b). It was not until 1906 that scientists first 
isolated the Bordetella Pertussis organism which causes pertussis (CDC, 2012b). In the 
beginning of the 20th century, pertussis was one of the most common diseases that 
affected children and was one of the main causes of childhood mortality (CDC, 2012b).   
Before the pertussis vaccine was discovered in the 1940’s, an average of 175,000 cases 
of pertussis were diagnosed each year in the United States (CDC, 2012b). After 
implementation of the vaccine s, the rate of pertussis started to decline. The annual 
reported cases of pertussis in the United States was less than 15,000 in the 1960s, less 
than 5,000 in the 1970s, and less than 2,500 in the 1980’s and 1990’s (CDC, 2012b). 
For unknown reasons the rate of pertussis slowly started to creep up. By 2004, there 
were over 25,000 cases of pertussis reported in the US (CDC, 2012a). According to the 
Center for Disease Control and Prevention (CDC) in 2010, there were 27,750 cases of 
pertussis in the United States (CDC, 2012a). The CDC states “the primary goal of 
pertussis outbreak control efforts is to decrease morbidity (amount of disease) and 
mortality (death) among infants; a secondary goal is to decrease morbidity among 
persons of all ages” (CDC, 2012a, p.1). To do so, current guidelines suggest mothers on 
postpartum units receive Tetanus, Diphtheria, and Acellular Pertussis (Tdap) vaccines 
before discharge to help reduce the number of infants who may be diagnosed with 
pertussis, which could result in death (2006). The National Network for Immunizations 
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and Information (NNII, 2011a) states there were 16,858 cases of pertussis in children 
under 6 months old in 2009 and 50 out of every 10,000 children less than one who 
develop pertussis will die from it. Pertussis is worse for infants three months of age and 
less, as most cases tend to be severe which may result in death. 
According to the Advisory Committee on Immunization Practices (ACIP), 
“patients with pertussis, including new mothers, are the identified source of B. pertussis 
infection in less than 25% of pertussis cases in early infancy, when rates for 
complications and fatalities are highest” (Murphy et al., 2008, p. 1). Murphy et al. (2008) 
recommend pertussis vaccinations for all adolescent and adult women of childbearing 
age. Clinicians should be assessing the status of Tdap vaccine for each patient during 
routine visits and physicals. Through assessment of vaccination status, health care 
providers can determine who needs immunization for pertussis, and in turn help prevent 
spread of pertussis by immunizing patients and their family members who may come in 
contact with infants (Murphy et al., 2008). 
Statement of Problem 
Data from the literature supporting the need for the project. The best way to 
prevent pertussis and pertussis outbreaks is through vaccination. The CDC has shown 
that pertussis vaccinations do not last a lifetime, as originally thought, therefore the CDC 
recommends Tdap vaccination for adults which protects them against pertussis. 
Currently, the CDC recommends adults ages 19-64 years of age receive a single dose 
of Tdap if they have not received the vaccine at all. For adults who have had a tetanus 
diphtheria (TD) booster within the last ten years, the CDC recommends they still get the 
Tdap for protection against pertussis. They recommend any adult who may come in 
contact with infants less than 12 months old receive a Tdap vaccine. If possible, women 
who plan to become pregnant should receive the vaccine before getting pregnant. 
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Women who are pregnant should receive the vaccine immediately postpartum if they 
have not had the Tdap vaccine in the past two years (Kretsinger et al., 2006).   
Pertussis will occur in 90% of people who are not vaccinated and live with 
someone who has the disease (NNII, 2011a). Pertussis disease is readily spread from 
one person to another, when someone who is infected with the disease, coughs or 
sneezes (NNII, 2011a). Vaccination against pertussis not only decreases the chances of 
that person contracting the disease, but also helps protect those who cannot receive the 
vaccine for specific reasons; this is called community immunity and can lower both 
severity and death rates (NNII, 2011b). In recent years, pertussis outbreaks have been 
reported in the US. In 2006, Cook County, Illinois had a pertussis outbreak. Numerous 
times the school district recommended protecting students against pertussis by getting 
the Tdap vaccine. It was not until a school based Tdap vaccination clinic was 
implemented, that students actually received the vaccines (CDC, 2012b). It took the 
school district bringing the vaccines to the students to make sure every student was 
vaccinated. During the first half of 2012, 37 states in the US reported an increase in 
pertussis cases compared to the year before (CDC, 2012a). Washington State reported 
an epidemic of pertussis in April; 2,883 cases of pertussis were reported from January 
until April 2012. In July 2012, the CDC reported that the current pertussis outbreak was 
the worst in over 50 years. From January 2012 through July 2012, 18,000 cases of 
pertussis were reported resulting in nine infant deaths. Additionally, less than 8% of 
adults in the US were vaccinated against pertussis (Hanwerker, 2012).  
According to Dr. Mark Sawyers, chairperson of the pertussis work group for the 
CDC, “Our biggest work is to get adults immunized. This is particularly relevant to 
pregnant women and new grandparents, who will have contact with infants” (Hanwerker, 
2012, p.9). Castagnini, Healy, Rench, Wootton, and Munoz (2011) implemented a 
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standing order for the Tdap vaccine on the postpartum unit in a Texas hospital and 
doubled the number of vaccines given to mothers. By having the vaccine readily 
available, the number of mothers who received the vaccine dramatically increased. If 
patients are not offered the vaccine, they are less likely to receive it since most patients 
are not familiar with pertussis, and need education regarding the importance of the 
vaccine.  
Data from the clinical agency supporting the need for the project. The EBP 
project was implemented at a Midwestern community hospital with 220 private rooms, 22 
ER rooms, and 12 ICU rooms. The OB unit has 10 private birthing suits and four triage 
rooms. From June 2011 through May 2012, 59 Tdap vaccines were administered to 
postpartum women on the unit. In that time frame, 532 deliveries were performed on the 
OB unit, thus only 10.1% of postpartum patients were vaccinated. The OB nurse 
manager and head OB physician were concerned with the low number of vaccinations 
administered and wanted to do something to increase the vaccination rate. A standing 
order for Tdap vaccine administration to postpartum mothers was already in place, but 
the vaccine was not being offered as outlined in the unit policy. The unit policy was 
consistent with ACIP guidelines which recommend administering Tdap immediately 
postpartum. The unit nurses needed education on the importance of the vaccine and 
increasing the number of vaccines administered on the unit to help prevent the spread of 
pertussis. Also the unit needed a specific procedure outlining when postpartum nurses 
would administer the vaccine.  
Identify Compelling Clinical Question 
The purpose of this EBP project was to determine if nursing education and 
implementation of a revised Tdap postpartum policy that includes a patient education 
component and standardization of vaccine delivery affected the Tdap vaccine 
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acceptance rate among postpartum women. A secondary purpose was determined if 
there was a relationship between characteristics of postpartum women and Tdap 
vaccine acceptance. An overall goal of the project was to decrease the transmission of 
pertussis from mother to infant which would, decrease the number of infants who 
become severely ill and potentially die from this disease. The project was developed 
through the process of clinical inquiry in which clinicians appraise different sources to 
determine what the best treatment options are for a particular action (Melnyk& Fineout-
Overholt, 2011).  
According to Melnyk and Fineout-Overholt (2011), once a clinical inquiry is 
encountered, a clinical question can be developed. The PICOT question for this EBP 
project was: In postpartum mothers, what is the effect of nursing education and 
implementation of a revised Tdap postpartum policy that includes a patient education 
component and standardization of vaccine delivery on the Tdap vaccine acceptance rate 
over a three month period?  
  Significance of the Project. The main goal during an outbreak of pertussis is to 
decrease the morbidity and mortality rates of infants (CDC, 2012a). One way to 
decrease the rate of transmission is to vaccinate. Currently only 8% of adults are up to 
date regarding their Tdap vaccinations. This is a significant problem. Unvaccinated 
adults can spread the pertussis disease to other adults, children, and infants. Within the 
first five months of 2012, the United States had 18,000 cases of pertussis and the 
number continues to rise (Handwerker, 2012). Pertussis cases peak in number every 3-5 
years (CDC, 2012b). If healthcare providers can increase the number of adults 
vaccinated, especially postpartum mothers, they may be able to decrease the number of 
pertussis cases, and end the cycle of pertussis outbreaks. 
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CHAPTER 2 
THEORETICAL FRAMEWORK AND REVIEW OF LITERATURE 
Evidence Based Practice (EBP) is key to successfully delivering the highest 
quality of care and ensuring the best outcomes possible for patients (Melnyk & Fineout-
Overtholt, 2011). According to Melnyk and Fineout-Overholt (2011), transformation of 
current practice should be guided by a conceptual model or framework. Frameworks are 
used to help predict and explain health behavior, and to provide a foundation for studies 
(Hall, 2012). The conceptual framework that guided this EBP project was the Health 
Belief Model (HBM) and the evidence based practice model was John Hopkins Nursing 
Evidence-Based Practice Model (JHNEBPM). The HBM helped predict and explain 
patients’ behaviors about receiving the Tdap vaccine. This model guided the 
communication components between the nurses and patients regarding education and 
administration of the vaccine. On the other hand, the JHNEBPM facilitated the 
translation of evidence into practice. The purpose of this EBP project was to determine if 
nursing education and implementation of a revised Tdap postpartum policy that includes 
a patient education component and standardization of vaccine delivery affected the Tdap 
vaccine acceptance rate among postpartum women.  
Theoretical Framework  
Overview of HBM. The HBM was developed by Hochbaum, Rosenstock, and  
Kegals from the US Public service office, in the 1950’s (University of Twente, 2012). The 
model is a guide for health care personnel in planning communication components of 
health care education programs. The HBM is one of the most commonly used 
conceptual frameworks for health promotion and health education (Hayden & Patterson, 
2009). This model was developed to explain the different beliefs that should be 
assessed for improved communication to allow positive health behaviors to result 
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(Carpenter, 2010). The HBM is an interpersonal framework where humans use a 
multidimensional approach in decision making towards health behaviors (Hall, 2012). 
The premise of the model is that people are more likely to act in healthy ways, if they 
know or believe the action will prevent a negative outcome that will affect them 
(Carpenter, 2010). 
The HBM has been used in studies that range from prevention of colon cancer to 
determining exercise behavioral changes in diabetics. According to the HBM model, 
behavior change is largely attributed to cognitive decision-making (Fingfged, 
Wongvatunyu, Conn, Grando, & Russel, 2003). The HBM attributes health behavior 
changes to the initiation of readiness for action. This readiness is based on balancing 
multiple perceptions regarding severity, susceptibility, benefits, and barriers (Fingfged et 
al., 2003).  
The first perception is perceived seriousness. Perceived seriousness addresses 
the individual’s thoughts about the severity of the illness or disease. The stronger the 
person’s perception of the severity of the disease and outcome, the more likely the 
individual will try to avoid the outcome (Roden, 2004). The individual will take whatever 
action necessary to prevent the disease or change the severity of the outcome.  
The second perception is perceived susceptibility. Perceived susceptibility 
includes the ideas or thoughts an individual has about possible risk or the possibility of 
getting a disease. When one believes their risk for a disease is greater, that individual is 
more likely to try and prevent that specific disease. An individual is more likely to be 
motivated to act in healthy ways (Roden, 2004). Therefore, an individual will make better 
health choices to prevent an illness, if the possibilities of contracting a disease or illness 
are at an increased risk. 
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The third perception is perceived benefits. A perceived benefit is an individual’s 
thoughts or ideas of the usefulness of changing behavior or adapting a new behavior to 
prevent a disease. An individual must understand and perceive the new behavior or 
change in behavior will cause a positive benefit (Roden, 2004). When the individual 
perceives that this change can cause a positive outcome, he/she is more likely to 
change the behavior to achieve this benefit. 
The fourth and final perception is perceived barriers. A perceived barrier is an 
individual’s observation of barriers that are preventing adaption or making a change in 
behavior. It is very important for an individual to believe the benefits of the change 
outweigh the risks of not enduring the specific change (Roden, 2004). If there are strong 
barriers preventing the behavior or change, individuals are less likely to initiate any 
behavior change.  Most individuals do not like change; therefore, perceived barriers are 
the strongest determinates of behavior change.   
There are three key concepts that can affect each perception and in return affect 
behavior: (a) variable, (b) action cue, and (c) self-efficiency (Glanz, Rimer, & Viswanat  
(2008). Each perception can be modified by different variables and can influence 
personal perceptions and thoughts. Variables are different characteristics such as age, 
culture, race, and education level. Redding, Rossi, Rossi, Velicer, & Prochaska, (2003) 
identified how an individual values their own health and how concerned the individual is 
about their overall health as a variable. For example, individuals that are concerned 
about their overall health and well-being, are more likely to exercise and eat right, than 
those who have little or no concern about their health (Redding et al., 2003). It is a 
variable that can affect individual behavior.  
Behavior is also affected by actions cues. Action cues are people, events, or 
ideas that influence an individual to change behavior. Action cues could be reminders to 
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see the doctor or someone else getting sick. Action cues trigger an alert to change a 
particular behavior. While action cues are acknowledged to promote behavioral 
changes, they are the most under developed and rarely used measure of the model 
(Carpenter, 2010).  
Another key item that can affect behavior is self-efficacy. Self-efficacy is an 
individual’s ability to carry out an action. An individual usually does not carry out a new 
action unless he/she believes he/she will be able to perform the necessary action to 
make the health related change. Individuals are more likely to fail at achieving something 
when they do not believe they can do it (Downing-Matibag and Geisinger, 2009). Action 
cues, variables, and self-efficacy can affect each perception and in turn affect behavior, 
yet behavior changes are necessary to promote change leading to good health.  
Numerous researchers have used the HBM model to guide research and EBP 
studies. Hall (2012) used the HBM as the cognitive framework to explain and predict 
behavior related to contraception. Hall (2012) performed a literature review of articles 
that used the HBM as a framework to discuss and predict behaviors related to 
contraception. According to Hall, the HBM helps to identify and predict factors that 
influence the use of contraception. The perceived susceptibility and seriousness of 
pregnancy cues individuals to change behavior and use contraception to avoid the threat 
of an unwanted pregnancy. The possibility of an unwanted pregnancy and the potential 
outcomes such as abortion, parenthood, and birth provide incentives for women to use 
contraception. The perceived barriers of contraception however are the possible side 
effects, such as headache, weight gain, and mood change, and the inconvenience of 
taking a medication on a regular basis. The perceived benefits are prevention of 
pregnancy and its complications. The cues to action could be missed periods, concerns 
proposed by a health care provider, or concerns from a partner. Hall concluded that the 
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HBM can direct family planning and practice and provide a framework to understand 
modern contraceptive behaviors.  
Roden (2004) used the HBM to show how nurses can provide guidance for 
families when using health promotion. In this study, Roden combined the HBM and 
Ajzen’s Theory of Planned Behavior. Roden believed the HBM model needed to be 
revised from its original form to provide the proper guidance for the study. She argued 
that if the HBM is to be applied to health promotion, it would need two additional 
components to the four perceptions presented in the original model. The first component  
was an improvement in the decision making ability in regards to economy and 
environmental factor influences that can prevent families from making good health 
behavior decisions (Roden, 2004). The second component  was the behavioral intention 
(BI) construct from the Theory of Planned Behavior that increased the logical 
explanation, clarity, and accuracy of the model and lead to the improvement of predicting 
health promoting behaviors (Roden, 2004). Both components were believed to help 
improve the predictability of health promoting behaviors.   
Carpenter (2010) performed a meta-analysis including 18 studies to determine if 
variables of the HBM could longitudinally predict individual behaviors. The author 
reported the findings of each of the four predictors. Severity was shown to be a low 
predictor of behavior. Knowing the severity of a negative health outcome did not appear 
to predict the adoption of a new behavior. Susceptibility had almost no effect on the 
individual’s probability of changing behavior to avoid a negative health outcome. The 
perception of benefit was consistently a positive predictor of behavior. The individual 
was more likely to perform a behavior change to prevent a negative health outcome if 
they knew the benefit of the behavior change. The largest predictor was the perception 
of the individual’s barriers to performing a behavior change. If individuals could perceive 
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overcoming barriers, they were more likely to change their behavior. Overall, Carpenter 
(2010) concluded the perceptions of barriers and benefits were good predictors of an 
individual’s behavior.  
The HBM model has been used in many health care settings. It can be used to 
guide communication for health promotion with patients. Some researchers have used 
the model to help predict the likelihood of a behavior, ranging from the use of 
contraception to women getting mammograms. Some researchers have found the HBM 
lacks a few components needed for health promotion, but adapted the model using 
specific components from other models.  
Strengths and weaknesses of the HMB. The HBM model has been used to 
predict and explain behaviors associated with positive health outcomes and has been 
replicated numerous times (Carpenter, 2010). Another strength is that the HBM can be 
applied across a broad spectrum of health related topics and behaviors. It predicts and 
describes possible patient actions to a certain health related behavior. A third strength is 
that it can help develop testable predictions. Redding et al. (2000) stated the HBM has 
the longest history out of the four most commonly used health behavior change models. 
According to Smith et al. (2011), the HBM is simplistic in organizing topics and was 
originally developed to understand why people do not get vaccines. Thus the HBM was 
well suited to guide this EBP project, which aimed to increase the Tdap vaccine 
acceptance rate of postpartum women. The model uses an individual’s own attitudes 
and beliefs, which ultimately can affect their actions. Though there are several strengths 
which make this model very versatile and applicable, it also has weaknesses.  
Some researchers have identified the main weakness of the HBM as 
inconsistency in predicting behaviors (National Institute for Health and Clinical 
Excellence, 2007). Most of the research on the HBM focuses directly on the four 
12 
 
 
 
 
perceptions of the model and results regarding the ability of the perceptions to predict 
behavior are not always consistent. Lack of research on specific components of the 
model has been noted by certain researchers (Roden, 2004). Researchers have also 
noted that this model does not address health-related belief systems outside of Western 
culture (Finfgeld et. al, 2003). There is presently little literature on action cues or 
variables to discuss them in extensive detail. More research is needed on these 
concepts.  
HBM applied to EBP project. The HBM guided the EBP project to implement a 
policy focusing on the administration of the Tdap vaccine to postpartum mothers, before 
they leave the OB unit. Administration of the Tdap vaccine to postpartum mothers is one 
way of preventing the spread of pertussis from mother to their infants and children. The 
perceived barriers to implementing this project were predicted using the HBM. These 
barriers were addressed to prevent negative outcomes. By offering the vaccine to 
mothers, health promotion through education was accomplished. When the mother 
received the vaccine, she changed a behavior to prevent pertussis, which she is 
susceptible to acquire. In turn, the behavior change helped prevent transmission of 
pertussis to her infant as well.  
When a mother was first admitted to the OB unit, the perceived susceptibility and 
seriousness of pertussis was addressed. Teaching about the need for Tdap vaccine and 
severity of pertussis was performed by the nurse. An educational hand-out which 
addressed the seriousness of pertussis and recommendations regarding who should 
receive the vaccine was given to the mother. 
After teaching occurred and the mother’s questions were answered, the nurse 
offered the Tdap vaccine to the mother. During interaction with the patient, the nurse 
assessed possible barriers the mother may have encountered. If the patient or nurse 
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identified barriers to administering the vaccine, the nurse addressed those barriers. 
Since the vaccine was administered in the hospital, before the mother was released, the 
barriers of access, availability, cost, and knowledge were addressed. Lack of knowledge 
was a barrier many individuals encounter while considering the Tdap vaccine. 
Individuals, who do not understand why healthcare providers recommend the vaccine, 
are less likely to receive it. They must understand the benefits of the vaccine and the 
actions they were taking. This barrier was addressed when the patient received the 
educational hand-out (Appendix B) and the nurse instructed them about the vaccine. 
The handout consisted of pertussis statistics, the primary goal of the CDC in a pertussis 
outbreak, and an explanation of the steps the nurse would be taking to implement the 
Tdap policy for postpartum mothers properly.  
The barriers of access, cost, and availability were addressed by offering the 
vaccine in the hospital. When the vaccine is given before discharge from the hospital, 
the individual does not have to worry about how they will pay for the vaccine at that time, 
nor where and when they will be able to receive it. Medicare, Medicaid, and most 
commercial insurance policies cover the vaccine. Other barriers, negative consequences 
of getting an injection and the possible side effects which include pain from the injection 
and soreness in the arm, were addressed by the nurse during the education component. 
Patients were instructed about application of ice at the injection site and over the counter 
analgesics to alleviate side effects.    
The perceived benefits of the mother receiving the vaccine, included not only 
decreasing the mother’s probability of getting pertussis, but also the probability of her 
newborn and other children contracting the disease. Other benefits of the vaccine 
discussed with the mother were prevention of tetanus and diphtheria.  
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Action cues were used throughout the mother’s stay on the OB/postpartum unit. 
One action cue was a reminder for the mother to receive the Tdap vaccine before she  
left the unit. Other action cues included the education the nurses provided and the 
educational handout that supported the information the nurses provided. Additionally, 
physicians provided reinforcement to the mothers about the importance of being 
vaccinated to prevent the disease. These action cues were strategies put in place to 
bring awareness to the patients. These cues prepared the patient for the readiness to 
take action and receive the Tdap vaccine while in the hospital. 
Self-efficacy is the individual’s confidence in their ability to achieve a specific 
action (Redding et al., 2003). To maintain self-efficacy, each mother made her own 
decision whether or not to receive the vaccine. The nurses provided education and 
support to the mother to encourage the behavior change, receiving the Tdap vaccine. 
The training and support increased the confidence level of the mothers and promoted 
understanding about the vaccine and its benefits, thus promoting vaccine acceptance. 
Not only can self-efficacy have an effect on behavior, but different variables encountered 
by individuals also affected self-efficacy.  
Variables that may have affected whether mothers opted to receive the Tdap 
vaccine include the patient’s age and socioeconomic status. Smith et al. (2011) reported 
children between 24 and 35 months of age did not receive the Tdap vaccine because 
their parents either refused or delayed the vaccine. The children were in households that 
were below poverty level, had mothers were less than 30 years of age, yet had a college 
degree (Smith et al., 2011). Certain variables decreased the likelihood of the mother 
agreeing to receive the vaccine. Regardless, the use of the HBM greatly enhanced the 
patients to act and receive the vaccine before they left the unit.  
EPB Model  
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Overview of JHNEBPM. Evidence based practice projects use models to guide 
and implement the projects successfully. The JHNEBPM “facilitates bedside nursing in 
translating evidence to clinical, administrative, and educational practice” (Melnyk & 
Fineout-Overholt, 2011, p. 271). The use of EBP can influence health care decisions that 
improve the quality of care that patients receive (Newhouse, Dearholt, Poe, Pugh, & 
White, 2011). It provides a systematic approach for health care personnel to make 
decisions that will achieve the best practice for their patients and accountability for 
themselves and other health care professionals (Newhouse et al., 2011).  
The JHNEBPM uses the PET process to translate evidence into practice. There 
are three stages to the process: (a) practice question, (b) evidence, and (c) translation. 
The first step is to develop a practice question. The goals of this stage include identifying 
the EBP question, defining the scope of the practice, assigning a leader, and assembling 
a team. Since development of a question is sometimes, more difficult than answering the 
question itself, a question development tool is provided to guide the creation of a 
practice question.  
The second stage in the PET process is evidence. In the evidence stage, 
individuals use critical thinking to analyze, synthesize, and interpret information. Once 
the evidence is obtained, conclusions are formed from the information available. During 
the evaluation of information, the individual looks at four components of evidence: study 
design, quality, consistency, and directness (Newhouse et al., 2011).  
The John Hopkins Nursing Evidence-Based Practice Rating Scale consists of 
five levels of evidence. Level one includes experimental studies/randomized control trials 
(RCT) and meta-analysis of RCTs. Level two consists of quasi-experimental studies. 
Level three includes non-experimental studies, qualitative studies, and meta-syntheses. 
Level four involves opinions of nationally recognized experts based on research 
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evidence or expert consensus of panels. Level five is comprised of opinion of an 
individual expert based on non-research evidence (Newhouse et al., 2011). Additionally, 
the quality of evidence is rated using a letter grade of A, B, or C (Newhouse et al., 2011).  
The letter grade scale differs for research and non-research evidence. Research  
evidence defines A as high, consistent results, sufficient sample size, adequate 
control and definitive conclusions; consistent recommendation based on  
extensive literature reviews that include thoughtful reference to scientific 
evidence. B is defined as good, reasonably consistent results, sufficient sample 
size, some control, and fairly definitive conclusions; reasonably consistent 
recommendations based on fairly comprehensive literature review that includes 
some reference to scientific evidence. C is defined as low/major flaws, little 
evidence with inconsistent results, insufficient sample size, and conclusion 
cannot be drawn (Newhouse et al., 2011, p. 207).  
The non-research grading system is separated into two sections, Summative 
Reviews and Expert Opinions. The Summative Review, grade A, also known as high, 
consists of  
reproducible search strategies, consistent results with sufficient  numbers of well-
designed studies; criteria-based evaluation of scientific strength and quality of 
included studies, and definitive conclusions. Grade B, also known as good, 
reasonably through and appropriate search; reasonable consistent results, 
sufficient numbers of well-designed studies, evaluation of strengths and 
limitations of included studies, and with fairly definitive results. Grade C, also 
known as low/major flaws, below par, poorly defined or limited search strategies; 
insufficient evidence with inconsistent results, conclusions cannot be drawn 
(Newhouse et al., 2011, p. 211).  
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The third and final stage of the PET process is translation. During this stage, the 
individual determines if the practice change recommendations are able to be 
implemented in their specific setting (Newhouse et al., 2011). To determine if a specific 
change is feasible, the change must be examined. When implementing a practice 
change in a specific setting, requirements of the nurses and the potential effects of the 
change all need to be considered (Newhouse et al., 2011). Once the determination is 
made to implement the change, then the action plan is developed. The action plan may 
include a new protocol, guideline, clinical pathway, or changes to existing protocols, 
guidelines, or clinical pathways (Newhouse et al., 2011). Once the plan has been 
developed and the proper changes have been approved by organizational leadership, 
then implementation can occur.  
Securing organizational leadership support is a critical factor in implementing any 
change. To obtain organizational leadership support, the budget must be estimated and 
the plan must be formulated (Newhouse et al., 2011). The comprehensive 
implementation plan should be presented to key leadership personnel in an effort to 
obtain support from the organization (Newhouse et al., 2011). The presentation will help 
the organization understand the exact plan and the expected outcomes. The 
organization may decide to implement the change across the whole organization or pilot 
the change and monitor the outcomes. Usually, organizations pilot the change in a 
specific area, instead of across the whole organization.  
For implementation to occur properly and successfully, all team members have to 
be informed, educated, and trained on practice changes (Newhouse et al., 2011). Once 
the change is implemented successfully, evaluation of the change can occur. During the 
evaluation, the degree to which the goals are met should be determined. Some 
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outcomes are expected and others are unexpected (Newhouse et al., 2011). The 
outcomes can help determine if alterations need to be made to the new change.  
After the implementation is evaluated, reporting the results and findings to the 
organizational leaders is next (Newhouse et al., 2011). The organizational leaders will 
determine if the desired outcomes are supported enough to be implemented across the 
whole organization. The final step is to communicate the results to external sources 
(Newhouse et al, 2011). Therefore the findings of this EBP project can help not only a 
single organization, but multiple ones.  
JHNEBPM applied to EBP project. Consistent with JHNEBPM, the EBP project 
began with developing a practice question. The OB unit manager identified that the 
postpartum mothers were not receiving the Tdap vaccine before discharge from the unit. 
Stiller (2011) identified that pertussis is being transmitted from close family members to 
infants without the transmitters even knowing they have it. The Advisory Committee on 
Immunization Practices (ACIP) strongly recommends the use of pertussis vaccine in 
postpartum mothers to decrease the transmission of pertussis to the infant (Clark, 
Adolphe, Davis, Cowan, & Kretsinger, 2006). The clinical problem is clear and concise, 
but how to fix it is the challenge. The DNP student and the OB nurse manager discussed 
the current unit policy for administering the Tdap vaccine and the need to increase the 
number of the vaccines given. After the discussions, the second stage was 
implemented.  
 The second stage of the process consisted of conducting a systematic review of 
the literature to identify the best evidence to answer this clinical problem. Once the 
evidence was selected, appraisal and synthesis were performed. Appraisal was 
performed by using the John Hopkins Nursing Evidence-Based Practice Rating Scale 
thereby determining the level and quality of each piece of evidence. Synthesis of the 
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evidence was performed and practice recommendations were developed for the EBP 
project. Recommendations included educating the patients on the harm pertussis can 
cause through discussion and a handout, and administering the vaccine immediately 
during the postpartum period. 
 The third stage is translation. It was determined that giving the Tdap vaccine to 
postpartum women while on the OB unit is feasible for this practice setting. The 
outcomes of the EBP project were determined. The main outcome was to monitor the 
acceptance rate of Tdap vaccinations administered to postpartum women prior to 
discharge from unit. Prior to implementing the Tdap administration on the postpartum 
unit, the nurses were educated on the change in the policy. This action plan was then 
implemented. After the changes were implemented for three months, the Tdap vaccine 
acceptance rate was calculated. This vaccine acceptance rate was compared to the 
three month pre-intervention acceptance rate. Once the outcome was evaluated, the 
final report was shared with the organizational leaders.   
Literature Search 
Sources of evidence. A literature search was performed to identify sources of 
evidence to address the PICOT question “In postpartum mothers, what is the effect of 
nursing education and implementation of a revised Tdap postpartum policy that includes 
a patient education component and standardization of vaccine delivery on the Tdap 
vaccine acceptance rate over a three month period?” Databases used were Cochrane 
Database of Systematic Review, Cumulative Index to Nursing and Allied Health 
Literature (CINAHL), the Joanna Briggs Institute Clinical Online Network of Evidence for 
Care and Therapeutics (JBI COnNECT), MEDLINE, and National Guideline 
Clearinghouse.  
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Key words used included pertussis vaccine, pertussis, whooping cough vaccine, 
whooping cough, and postpartum. Inclusion criteria were age 19-44, English language, 
and peer reviewed. The searches lead to 34 publications from various databases: 
Cochrane Library, seven; CINHAL, nine; JBI, zero; MEDLINE, 10; and National 
Guideline Clearinghouse, eight.  
Of the seven articles that resulted from searching the Cochrane Library, all were 
excluded since they did not pertain to Tdap administration in postpartum women 
(Altunaiji, Kukuruzovic, Curtis, & Massie,  2007; Bar-On, Goldberg, Hellmann, & 
Leibovici, 2012; Bettiol, et al., 2012; Chen, Zhuo, Yuan, Wang, & Wu, 2008; Kapoor, 
Tharyan, Kant, Balraj, & Shemilt,  2010; Oyo-Ita , Nwachukwu, Oringanje, & Meremikwu, 
2011; Zhang, Prietsch, Axelsson, & Halperin, 2012). Nine articles resulted from the 
CINHAL search; five articles were included in the review, thus four of the articles were 
excluded. The five articles that were included in the literature review discuss 
recommendations for using Tdap in postpartum mothers (Jackson, 2008; Lee et al., 
2005; Stiller, 2011; Tan & Gerbie 2010; Trick et al. 2010). Three articles were excluded 
because they discussed administering Tdap in pregnant mothers (Gall, 2008; Gall 2012; 
Shakib et al., 2010). Another article (DeSanto, 2011) was excluded because it was a 
poster presentation summary and did not include sufficient information to support 
discussion.   
JBI yielded no results when searching the key words. MEDLINE search revealed 
10 articles. Three of the articles were included in the literature review because they 
addressed administering Tdap to postpartum mothers (Cheng et al., 2010; Clark et al., 
2006; Krestinger et al., 2006).Two of them were duplicates from CINHAL (Lee et al., 
2005; Tan & Gerbie, 2010), and thus already included in the literature review. Four of the 
publications that were excluded from the study discussed Tdap vaccine pertaining to 
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kinetic antibodies, cocooning, and administration in health care workers (Halperin et al., 
2011; Healy, Rench, & Baker, (2011); Healy, Rench, Castagnini, & Baker, 2009; Tan & 
Gerbie, 2009). The final publication excluded talked about Tdap in pregnant women 
(Updated recommendations for use of tetanus toxoid, reduced toxoid and acellular 
pertussis vaccine in pregnant women and person who have anticipate having close 
contact with an infant aged < 12 months---- Advisory Committee on Immunization 
Practices, 2011). 
The National Guideline Clearinghouse resulted in eight guidelines. One guideline 
will be used for the literature review (Murphy et al., 2008). Seven of the guidelines were 
excluded because they did not discuss Tdap vaccination, and/or they only addressed 
overall vaccination of adults (ACIP 2012; Akkerman et al., 2012; Department of Veteran 
Affairs, Department of Defense, 2009; Kroger, Sumaya, Pickering, & Atkinson, 2011; 
Nordin et al., 2007; University Michigan Health Systems, 2011; Wilkinson et al., 2011). 
Once the body of literature for review was completed, citation chasing was performed. 
Two articles were identified, one article was excluded because it was greater than 20 
years old (Beiter, Lewis, Pineda, & Cheery, 1993), and the other article was included in 
the review (Castahnini et al. 2011). Ten articles were reviewed, three non-experimental 
descriptive studies, three quasi experimental studies, two practice recommendations, 
and two expert opinion. 
Levels of evidence. Once the articles for review were determined, appraisal and 
synthesis occurred. The John Hopkins Nursing Evidence-Based Practice Evidence 
Rating Scale was used to rate the strength and quality of evidence. There is one tool for 
research evidence appraisal and one for non-research evidence appraisal. The strength 
of the evidence is rated from I to III for research and IV to V for non-research. The 
highest level of evidence is I and the lowest level of evidence is V. Level I consists of 
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experimental studies, randomized control trials, or meta-analysis of randomized control 
trials. Studies may be blind, double blind or non-blind. Level II includes quasi-
experimental studies. Level III includes non-experimental studies, qualitative studies, 
and meta-syntheses. For non-research literature, level IV consists of systematic reviews 
and clinical practice guidelines based on research evidence or expert panels and level V 
includes individual expert opinion based on nonresearch evidence. The quality of 
evidence is rated on a letter scale: A high, B Good, and C Low quality or major flaws.   
Appraisal of relevant evidence. Literature appraisal is presented in Table 2.1. 
Castagnini et al. (2011) did a cross-sectional pre-intervention and post-intervention study 
comparing the effect of implementing a standing order for Tdap vaccine administration 
on the maternal postpartum unit at Ben Taub General Hospital in Houston, Texas. There 
were a total of 5719 births on the unit during the pre-intervention period and 5416 births 
during the post intervention period. During the study period, 514 infants contracted 
pertussis; 378 infants contracted the disease during the pre-intervention period and 136 
infants contracted pertussis during the post intervention period. The data collection 
method was clear and concise. The data showed the number of pertussis cases 
decreased from 378 cases pre-intervention to 136 pertussis cases post intervention, 
which was a significant decrease of 37%. The authors concluded it may be too late to 
give the Tdap vaccine to postpartum women for protection against infants. Also 
programs need to be developed to vaccinate all adults, not just postpartum women.   
A national random survey of 400 physicians was performed by Clark et al. 
(2006). The purpose of the study was to determine views on administration the Tdap 
vaccine for adults. The survey included all osteopathic and allopathic physicians that 
where obstetricians and/or gynecologists in the United States. This population was 
targeted because of their direct contact with women who were in close contact with 
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Table 2.1 
 
Literature Appraisal 
      
Author/Year/Title Purpose Sample Design/Measurement  Evidence Rating 
Strength/Quality 
Findings 
      
Castahnini et al./ 
2011/ Impact of 
Maternal postpartum 
tetanus and 
diphtheria toxoids 
and acellular 
pertussis 
immunization on 
infant pertussis 
infection 
 
 
 
 
 
 
 
 
 
Cheng et al./2010/ 
Factors influencing 
women’s decisions 
regarding pertussis 
vaccine: A decision-
making study in the 
Evaluate routine 
maternal postpartum 
Tdap immunization 
and its effect in 
preventing infants 
less than six month 
old from getting 
pertussis. 
 
 
 
 
 
 
 
 
 
 
 
Determine what 
factors influence 
postpartum mothers 
to receive Tdap 
vaccine and if 
vaccine efficacy and 
5719 birth pre-
intervention  
 
5419 birth post 
intervention.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1398 out of 1519 
women who 
delivered at Chang 
Gung Memorial 
hospital  
 
Quasi-experimental 
cross- sectional study 
using pre intervention 
and post intervention 
data from four Texas 
children hospitals. 
Compared the effects 
of implementing a 
standing order for Tdap 
on postpartum unit. 
The study compared 
the pre intervention 
periods without a 
standing order to the 
post intervention with a 
standing order. 
 
 
 
Non-experimental 
descriptive study. 
Three page survey with 
25 questions. The  
survey was multiple 
choice asking about 
Level II/ A High 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Level IV/ B Good 
 
 
 
 
 
Mean age of 
diagnosis of pertussis 
was 77 days old. 
 
Maybe too late to 
implement Tdap in 
postpartum mothers 
to help decrease the 
transmission of 
pertussis from mother 
to infant.  
 
378 infants acquired 
pertussis pre 
intervention.   
 
136 infants acquired 
post intervention 
 
Relying on personal 
recollection of Td 
cause less mothers to 
receive the vaccine.  
 
Those who declined 
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postpartum pertussis 
immunization 
program of a 
teaching hospital in 
Taiwan 
 
 
 
 
 
 
 
 
 
Clark et al./2006/ 
Attitudes of US 
obstetricians towards 
a combined tetanus-
diphtheria-acellular 
pertussis vaccine for 
adults. 
 
 
 
 
 
 
 
 
 
 
Jackson, S./2008/ 
Tdap education and 
administration during 
safety were part of 
their information 
needs. 
 
 
 
 
 
 
 
 
 
 
 
Describe 
obstetricians’ 
perspective of giving 
Tdap vaccines to 
mothers and adults 
who come into close 
contact with infants.  
 
 
 
 
 
 
 
 
 
 
To educate health 
professionals on the 
need to decrease 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
400 obstetricians 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N/A 
 
 
demographics, 
concerns about the 
vaccine safety, what 
information was 
needed to make an 
informed decision 
about the vaccine, what 
risk were  infants at , 
what influenced 
mothers to accept or 
decline the vaccine.  
 
 
 
Non-experimental         
descriptive study. Six 
specific items 
addressed in the 
survey: administration 
of influenza and MMR 
vaccines; likelihood of 
recommending Tdap 
vaccines to pregnant 
and postpartum 
women; barriers 
encountered when 
offering Tdap; who is 
responsible for 
prompting Tdap 
vaccines to patients.  
 
Expert Opinion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Level IV/ B Good 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Level V/ B Good 
 
 
the Tdap vaccine 
thought themselves 
and their babies were 
at low risk of getting 
pertussis.  
 
Women of child- 
bearing age should 
be educated on the 
risk of infants 
contracting pertussis, 
and ways to prevent 
it.  
 
OBGYN’s are likely to 
give Tdap vaccine.  
 
Tdap is safe in non-
pregnant women and 
men. 
 
Women planning to 
get pregnant and 
postpartum women 
should receive the 
Tdap vaccine.  
 
 
 
 
 
Tdap prevention and 
education programs 
are needed to prevent 
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postpartum periods 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Kretsinger et al./ 
2006 /Preventing 
tetanus, diphtheria, 
and pertussis among 
adults: Use of tetanus 
toxoid, reduced 
diphtheria toxoid and 
acellular pertussis 
vaccine 
 
 
 
pertussis in 
postpartum mothers, 
to decrease the rate 
of transmission to 
infants.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Provide practice 
recommendations for 
health care 
professionals to carry 
out immunizations for 
Tdap vaccine.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N/A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Practice 
Recommendations 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Level IV/ A High 
 
 
 
 
 
 
 
 
 
 
 
pertussis in adults 
and adolescents, 
which will help 
decrease the 
transmission rate to 
infants from mothers. 
 
Education of pertussis 
to parents and the 
use of the Tdap 
vaccine, could help 
reduce infant 
pertussis cases. 
 
Infants less than 12 
months of age are 
more likely to be 
affected by pertussis 
and potentially die 
from it than any other 
age group. 
 
Tdap should be 
administered to 
patient immediately 
postpartum if they 
have not had it before 
pregnancy. 
 
Administering Tdap 
vaccine postpartum, 
before the mother 
leaves the OB unit 
instead of the first 
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Lee et al./2005/ 
Pertussis in 
adolescent and 
adults: Should we 
vaccinate? 
 
 
 
 
 
 
 
 
 
Murphy et al./ 2008/ 
Prevention of 
pertussis, tetanus, 
and diphtheria among 
pregnant and 
postpartum women 
and their Infants. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evaluate health 
benefits, risks and 
cost of a national 
Tdap program 
 
 
 
 
 
 
 
 
 
 
Update of practice 
recommendations for 
health care 
professionals to carry 
out immunizations for 
Tdap vaccine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Six vaccination 
strategies: 
no vaccination, one 
time vaccination 
after 20, one time 
vaccination age 11, 
10 year booster 
vaccine of Tdap for  
adults and 
adolescents, 10 
year booster for 
adolescents, and 
postpartum mothers. 
 
N/A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-experimental 
Markov Model  
 
 
 
 
 
 
 
 
 
 
 
 
Practice 
Recommendations 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Level III/A High 
 
 
 
 
 
 
 
 
 
 
 
 
 
Level IV/ A High 
 
 
 
 
 
 
postpartum follow up 
visit, will help 
decrease the time 
frame the mother can 
transmit pertussis to 
their infants.  
 
Development of a 
hospital mechanism 
to provide postpartum 
Tdap is 
recommended.   
 
One time adult 
vaccination would 
prevent < 8% of 
cases. 
 
Adult and adolescent 
booster would prevent 
41% cases. 
 
One time adolescent 
vaccine would prevent 
36% of cases. 
 
 
Administer Tdap 
vaccine to pregnant 
women in second or 
third trimester if 
benefits outweigh 
risks.  
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Stiller /2011/ 
Preventing neonatal 
pertussis through 
maternal 
immunization. 
 
Tan & Gerbie /2010/ 
Pertusis and patient 
safety: Implementing 
Tdap vaccine in 
hospitals.  
 
 
 
 
 
 
 
Trick et al. /2010/ 
Using computer 
decision support to 
increase maternal 
postpartum tetanus, 
diphtheria, and 
acellular pertussis 
Vaccination. 
 
 
 
 
 
 
 
 
Explain the effects of 
immunizing mothers 
postpartum on the 
prevention of 
neonatal pertussis.  
 
Determine the effects 
of implementing the 
Tdap vaccine in 
postpartum and ER 
hospital settings. 
 
 
 
 
 
 
 
Evaluate the effects 
of computer-based 
clinical decision-
support algorithm on 
number of Tdap 
vaccinations given to 
postpartum mothers. 
 
 
 
 
 
 
 
 
 
N/A 
 
 
 
 
 
12,096 postpartum 
women. 
 
 
 
 
 
 
 
 
 
 
Pre intervention 
group n=183  
 
Post intervention 
group n=248  
 
 
 
 
 
 
 
 
 
Expert opinion 
 
 
 
 
 
Quasi- experimental 
One group posttest 
 
 
 
 
 
 
 
 
 
 
Quasi-experimental 
cohort study 
 
 
 
 
 
 
 
 
 
 
 
Level V/ A High 
 
 
 
 
 
Level II/ B Good 
 
 
 
 
 
 
 
 
 
 
 
Level II/ A High 
 
Administer Tdap 
vaccine to postpartum 
women immediately 
postpartum or as 
soon as possible 
postpartum. 
 
An effective vaccine 
strategy for pertussis 
immunizations needs 
to be developed.  
 
 
Hospital based 
programs to give 
Tdap vaccine can be 
implemented 
successfully as long 
as the key decision 
makers within the 
hospital and hospital 
personnel who will 
have a direct impact 
on giving the vaccine.  
 
Use of computer 
decision support 
increased the amount 
of Tdap vaccines 
given to postpartum 
mothers.  
 
Out of 67 patients 
who failed to receive 
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the Tdap vaccine, 34 
were due to patients 
order not being 
carried out and 30 
were because 
patients refused.  
 
Automated computer-
based system can 
significantly help 
improve patient care. 
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infants. The survey concluded that 78% of participating physicians would recommend 
administration of the Tdap vaccine to mothers immediately postpartum. The largest barrier 
perceived was the patient knowing when they last received a tetanus diphtheria (td) booster. 
Authors recommended that women who are going to become pregnant and women during the 
immediate postpartum period receive the Tdap vaccine. Limitations of this study included 
possible selection bias, as the surveys were mailed. Other limitations included that more 
respondents were board certified physicians while the majority of those who did not respond to 
the survey were not board certified. A strength of the study was the use of random sampling, 
the surveys were mailed out to a randomly selected group, which increased the probability of 
obtaining a representative sample of obstetrician gynecologist (OBGYN) physicians within the 
sampling frame. 
To determine the effects of six vaccination strategies, Lee et al. (2005) constructed a 
Markov Model. Researchers determined the health benefits, costs, risks, and cost 
effectiveness of the strategies. The six strategies were: a) no vaccination, b) one time 
vaccination at 11 years old, c) adolescent and adult vaccination with a 10 year booster, d) adult 
vaccination with a 10 year booster, e) one time vaccination at 20 years of age, and f) 
vaccination at postpartum. A review of literature was performed using Medline database, 
unpublished information from the CDC, and recent clinical trials on vaccines. Using the 
modified Delphi process, it was estimated that over a lifetime, approximately 85,000 cases of 
pertussis would occur if no vaccinations were provided. Immunizing adults and adolescents 
with a booster vaccine was estimated to be the best prevention of pertussis. One time 
adolescent vaccination would also prevent numerous cases, approximately 30,800. The rest of 
the strategies including postpartum vaccination administration reduced approximately 8% of 
pertussis cases. None of the strategies enabled a net savings for companies.  
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In a review, Jackson (2008) stated pertussis is highly contagious and transmitted by 
close contact from person to person. Between 2004 and 2005, over 50,000 pertussis cases 
were reported in the United States (Jackson, 2008). At Texas Children’s Hospital, greater than 
75% of infants infected with pertussis were infected by family members (Jackson, 2008). The 
author concluded that hospital providers and policymakers must understand the emergence of 
pertussis and its threat to the infant population (Jackson, 2008). Education to providers and 
parents was recommended to increase vaccinations of adults and decrease infant pertussis 
cases.  
Trick et al. (2010) used a computer-based clinical-support algorithm when implementing 
a Tdap vaccine program with postpartum mothers. Researchers performed a cohort study to 
compare the frequency of Tdap vaccines pre intervention and post intervention. The pre 
intervention and post intervention periods were 3 months and 15 days. The algorithm targeted 
women ages 14-45 years who had an order for iron. There were two exclusion criteria in the 
study, women who had a previous electronic order for Tdap or Td within two years, and women 
who had an order for phenytoin. The authors concluded that the use of computer-based clinical 
decision-support dramatically increased the number of Tdap vaccines given postpartum. 
Researchers in this study identified use of an electronic system as a study limitation; use of 
such a system is not universal. Some patients may have received the vaccine elsewhere and 
record of the vaccine would not be within the system. If everyone used the same electronic 
system, all health care providers could see what kind of care and interventions each person 
had received. Another weakness of the study was the use of an order for iron to trigger the 
Tdap algorithm. The use of a trigger may have missed some patients who did not receive iron 
during or after delivery. 
Cheng et al. (2010) performed a survey to determine what factors may influence 
postpartum women to receive the Tdap vaccine. Women were asked to participate in the 
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decision making survey during their first postpartum visit. The survey used an 11 item 
instrument to determine each participant’s perception of Tdap vaccine risk. Survey results of 
the women who received the Tdap vaccine were compared to those who did not receive the 
Tdap vaccine. Chi-square analysis was used to determine specific associations to mothers 
receiving the Tdap vaccine versus not receiving the vaccine. In the survey women selected the 
most common influence on their decision regarding acceptance of the Tdap vaccine. 
Researchers identified education during the third trimester as one of the most successful ways 
to implement the Tdap vaccine in postpartum women. Survey results indicated that the most 
common reason women received the Tdap vaccine was their belief that they could transmit 
pertussis to their infant. The second most common reason was the mother’s belief that 
pertussis was very common among infants, and the third most common reason was fear their 
infant would develop pertussis. The three main reasons women declined the Tdap vaccine 
were fear of side effects, mothers thinking their babies would not have a chance at getting 
pertussis, and the fear of what the Tdap vaccine could do to the infant while the mother was 
breastfeeding. The health belief model was used in the study to explain health seeking 
behaviors and how people see themselves contracting a disease. The authors concluded that 
patients were more likely to receive the Tdap vaccine if they knew about the vaccine risks and 
benefits. Authors concluded a need for a successful implementation plan to improve Tdap 
acceptance in postpartum mothers; however, specific recommendations regarding the 
implementation plan were not provided.  
Stiller (2010) authored an expert opinion article on pertussis prevention in neonates. In 
this article, the author reported that one third of infant cases of pertussis were transmitted from 
the mother and almost half of infant pertussis cases were transmitted from other family 
members. Stiller, reiterated the current recommendations which include vaccinating women 
before they become pregnant if they have not received a Td or Tdap vaccine within the last two 
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years or vaccinating women during the immediate postpartum. The author recommended 
implementation of a standing order for Tdap vaccine for postpartum mothers as this 
intervention may increase the Tdap vaccine acceptance rate. The author identified that 
hospitals need to develop some mechanism for postpartum mothers to receive Tdap before 
they are discharged from the OB unit. This could occur by incorporating the Tdap vaccine into 
existing order sets or through new standing orders.  
Tan and Gerbie (2010) implemented a research project that addressed the need to 
increase Tdap in postpartum and emergency room patients. In 2007, the Chicago Department 
of Public Health along with the CDC donated Tdap vaccines in an effort to increase the 
numbers of postpartum mothers who received the vaccine. In the research study, educational 
sessions for the postpartum staff, labor and delivery staff, and the OB/GYN physicians were 
held to teach healthcare providers the importance of Tdap administration in postpartum 
women. During an 18 month period following implementation of the study, 9,540 doses of Tdap 
were given on the OB unit to postpartum mothers. The authors suggested that hospitals 
implement programs and initiatives for postpartum mothers to receive the Tdap vaccine before 
they leave the postpartum unit. A weakness of the study was the lack of baseline data. Data 
regarding Tdap administration rates prior to project implementation were not provided, thus 
comparisons pre and post intervention could not be concluded. 
ACIP, an advisory committee composed of experts who provide guidance to the 
Secretary of the US Department of Health and Human Resources and the CDC, developed 
original practice recommendations and guidelines regarding pertussis vaccination in 2006, with 
updates in 2008. The categories of the guidelines are management, prevention, and treatment. 
The intended users are nurses, allied health, advanced practice nurses, hospitals, physician 
assistants, physicians, and public health departments. The target population for the 2006 
guidelines was adults; whereas the 2008 guidelines targeted pregnant and postpartum women 
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and their infants. The major difference in the guidelines from 2006 to 2008 is the ACIP now 
recommends that women receive the Tdap vaccine during the second or third trimester of 
pregnancy if the risks outweigh the benefits. 
The 2006 ACIP guidelines included the following recommendations:    
1) Adults aged 19–64 years should receive a single dose of Tdap to replace tetanus 
and diphtheria toxoids vaccine (Td) for booster immunization against tetanus, 
diphtheria, and pertussis if they received their last dose of Td >10 years earlier and they 
have not previously received Tdap; 2) intervals shorter than 10 years since the last Td 
may be used for booster protection against pertussis; 3) adults who have or who 
anticipate having close contact with an infant aged <12 months (e.g., parents, 
grandparents aged <65 years, child-care providers, and health-care personnel) should 
receive a single dose of Tdap to reduce the risk for transmitting pertussis. An interval as 
short as 2 years from the last Td is suggested; shorter intervals can be used. When 
possible, women should receive Tdap before becoming pregnant. Women who have 
not previously received Tdap should receive a dose of Tdap in the immediate 
postpartum period; 4) health-care personnel who work in hospitals or ambulatory care 
settings and have direct patient contact should receive a single dose of Tdap as soon 
as feasible if they have not previously received Tdap. An interval as short as 2 years 
from the last dose of Td is recommended; shorter intervals may be used. These 
recommendations for use of Tdap in health-care personnel are supported by the 
Healthcare Infection Control Practices Advisory Committee (HICPAC) (Kretsinger et al, 
2006, p. 3). 
In 2008, the ACIP updated the guidelines. These new recommendations included:  
1) receive Tdap in the immediate postpartum period before discharge from hospital or 
birthing center, 2) may receive Tdap at an interval as short as two years since the most 
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recent Td vaccine, 3) receive Td during pregnancy for tetanus and diphtheria protection 
when indicated, or 4) defer the Td vaccine indicated during pregnancy to substitute 
Tdap vaccine in the immediate postpartum period if the woman is likely to have 
sufficient protection against tetanus and diphtheria. Although pregnancy is not a 
contraindication for receiving Tdap vaccine, health-care providers should weigh the 
theoretical risks and benefits before choosing to administer Tdap vaccine to a pregnant 
woman (Murphy et al., 2008, p. 3). 
  To appraise the guidelines, the Appraisal of Guidelines for Research and Evaluation II 
(AGREE II) instrument (The AGREE Collaboration, 2009) was used. The instrument evaluates 
guidelines in six domains. The scoring for each domain ranges from one, which is strongly 
disagree, to seven, which is strongly agree. The guidelines scored greater than 85% in four out 
of six of the domains for the 2006 guidelines: (a) scope and purpose (97%), (b) stakeholder 
involvement (95%), (c) rigor of development (79%), (d) clarity and presentation (100%), (e) 
applicability (79%), and (f) editorial independence (86%). The rigor of development received a 
low score because the authors did not clearly state the strengths or limitations of the guidelines 
or explain the systematic methods used to search the evidence. The applicability scored low 
because minimal explanation of barriers to application, advice on how to implement the 
guidelines, and monitoring and auditing guideline success were provided. Through assessment 
of the guidelines with the AGREE II instrument, the 2006 guidelines are recommended for use. 
The updated version, 2008, of the guidelines added situations when the vaccine should be 
given, but did not address some of the lacking areas in the first set of guidelines. Therefore the 
second set of guidelines (2008) were not appraised, they just made additional 
recommendation, not a completely new set of recommendations.   
Numerous authors reference the guidelines from the ACIP. The ACIP guidelines 
recommend giving the Tdap vaccine to mothers immediately postpartum, but do not 
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recommend ways to implement the vaccine. Cheng et al. (2010) recommended education of 
both the nurses and patients and a standing order for the Tdap vaccine. More research is 
needed to determine best practice recommendations and implementation strategies.  
Construct EBP 
Synthesis of relevant literature. Researchers have confirmed that Tdap vaccines do 
not last a life time. Pertussis is one disease that can be controlled and prevented through 
vaccination, but at present is not (Tan and Gerbie, 2010). The majority of authors support 
administering the Tdap vaccine during the postpartum period via implementation of a hospital 
based program (Cheng et al., 2010; Clark et al., 2006; Jackson, 2008; Kretsinger et al., 2006; 
Lee at al., 2005; Stiller et al., 2011; Tan and Gerbie, 2010; and Trick et al., 2010;). One author 
did not support the Tdap vaccine administration to postpartum women (Castahnini et al., 2011). 
All authors reported the need for postpartum women to receive more information about the 
Tdap vaccine.  
  Mothers were shown to be responsible for one third of the pertussis transmissions to 
infants (Stiller, 2010). With the transmission rate being so significant from mothers to infants, 
Tan and Gerbie (2010) recommended that hospitals implement a vaccine program for 
postpartum women. The best way to implement Tdap vaccine programs in the hospital setting 
has yet to be identified. However, there are a several suggestions about ways to increase the 
Tdap administration rate within hospitals. Computer-based clinical-support was found to 
drastically increase the administration of Tdap vaccines (Trick et al., 2010). Education of 
healthcare providers including nursing staff of OB and postpartum units and OBGYN 
physicians, has been shown to increase the rate of Tdap administration (Cheng et al., 2010). 
Most OBGYN physicians support administering Tdap to postpartum women, who have not 
received a Td or Tdap booster within the last two years (Clark et al., 2006). Administration of 
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the Tdap vaccine can prevent the spread of pertussis from mothers to infants, especially if 
hospitals develop a Tdap vaccine program.  
Best practice recommendations. The current best practice guidelines are from the 
ACIP. The guidelines were published in 2006 and then updated in 2008. These best practice 
guidelines were implemented with postpartum mothers, in an effort to address the clinical 
question, ,”In postpartum mothers, what is the effect of nursing education and implementation 
of a revised Tdap postpartum policy that includes a patient education component and 
standardization of vaccine delivery on the Tdap vaccine acceptance rate over a three month 
period?”   
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CHAPTER 3 
 
IMPLEMENTATION OF PRACTICE CHANGE  
The purpose of this EBP project was to determine if nursing education and 
implementation of a revised Tdap postpartum policy that includes a patient education 
component and standardization of vaccine delivery affected the Tdap vaccine acceptance rate 
among postpartum women. To implement these practice changes collaboration among all 
healthcare providers involved in the care of these patients was essential. The ultimate goal of 
this EBP project was to increase the Tdap vaccine acceptance rate, which in turn would 
decrease the number of pertussis cases in infants.    
Setting   
The project took take place on the OB unit at a small community hospital in the 
Midwest. This 120 bed facility is part of a system that consists of three hospitals within 25 miles 
of each other. The hospital system is administered by the President of the board who oversees 
all hospitals; each individual hospital has a Chief Executive Officer and Chief Nursing Officer.  
The OB unit has 10 private rooms and four triage rooms. Each room on the OB unit is a 
private suite and allows for visitors 24 hours a day. Ten OB/GYN physicians use the facility for 
maternity patients. The birthing suites offer water births, midwifery deliveries, and a lactation 
consultant. The hospital uses electronic medical records for charting and recording purposes. 
There are 22 registered nurses (RNs), 5 obstetrics technicians, 1 RN fellow, and 2 unit 
secretaries that make up the staff for the OB unit. The OB unit performs approximately 580 
deliveries a year.  
Sample 
 The sample was comprised of women of any age who had recently delivered a baby 
and was a patient of the OB unit. Patients that meet the following inclusion criteria were offered 
the vaccine: women who had not received either Tdap or Td booster within the last 2 years, 
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were not allergic to any components of the Tdap vaccine, were not presently pregnant, and/or 
did not have any contradiction to the vaccine.  
Outcomes 
 The primary outcome of this EBP project was the Tdap vaccine acceptance rate. The 
vaccine acceptance rate was calculated for a three-month period following the policy 
implementation. This post intervention rate was compared to the vaccine acceptance rate 
obtained for a three-month period prior to policy implementation, the pre intervention phase. 
Secondary analysis investigated relationships between sample characteristics and vaccine 
acceptance.   
Intervention and Planning 
 The first step in the intervention of the EBP project was to revise the current TDAP 
policy for the OB unit. The Tdap unit policy revision included an educational component for the 
patients, standardization of when the vaccine was given, and contraindications for the vaccine 
(see Appendix A). The next step was to develop the educational components. The handout 
used was developed by the CDC and is titled “Td or Tdap Vaccine (Tetanus-Diphtheria or 
Tetanus-Diphtheria-Pertussis) What You Need to Know” (see Appendix B). The educational 
handout consisted of information about who should receive the vaccine, why it should be 
received, who should not receive it, and what diseases the vaccine protects against. Once the 
policy change was completed and the educational component was developed, the unit 
manager then approved the changes and forms. After the changes were approved, the nurses 
were educated on the new policy and patient education component.  
 Training sessions for each shift occurred over several days, at different times to ensure 
all shifts and all nurses were able to attend. During the training sessions, the nurses were 
introduced to the revised Tdap policy and the patient education component with a handout  
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(Apendix C) Questions were answered and any concerns were addressed during each training 
session. 
 When a patient came to the OB unit for admission for labor, complications, or 
monitoring, the patient was admitted to the unit by one of the nurses. Upon admission to the 
unit, the nurse asked a set of questions regarding the patient’s health and the reason for their 
visit to the unit. During the intake questions, the nurse educated the patient on the importance 
of Tdap vaccination and how pertussis can be spread to infants unknowingly.  At this time, the 
patient was also given the educational handout from the CDC on the Tdap vaccine. After 
delivery, the nurse administered the vaccine as soon as possible. If complications arose, or the 
mother had to have a C-section, the nurse addressed the vaccine administration once the 
mother was stable and able to receive the vaccine.  
Institution Review Board (IRB) approval was sought from the university and the hospital 
system. To ensure human right protection, all identifying factors of the patient such as name 
and medical record number  were kept locked in a cabinet until no longer needed and then 
destroyed by having it shredded. Information was reported as aggregate data only; no 
identifying information for individual patients was used.  
Data 
 Measures. The primary outcome data is nominal level data. The vaccines were either 
accepted, yes or not accepted, no. The demographic data, age, race, delivery status whether 
C-section or vaginal delivery, GP status, and type of insurance, are of varying levels. Years of 
age are ratio level data and race and insurance type are ordinal level data.  
Collection and management. The data regarding the number of Tdap vaccines 
administered and patients who delivered on the OB unit were tracked by accessing the OB unit 
delivery log. The delivery log was kept in the secured cabinet within the OB unit nurses’ station. 
The report listed both the patients that did and did not receive the Tdap vaccines. The DNP 
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student accessed the electronic medical record of each patient using a data collection tool to 
obtain demographic data.  
Management and analysis. The data collected throughout the study was kept in a 
locked cabinet within a private office. Chi square analysis was performed to determine if a 
difference in acceptance rates between the pre and post intervention periods were attributed to 
the intervention. Demographic data were examined using t-tests and chi-square analyses to 
determine if subjects in the pre intervention phase were similar to subjects in the post 
intervention phase. Also, the relationships between demographic characteristics and vaccine 
acceptance rate were compared.   
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CHAPTER 4 
FINDINGS 
The purpose of this EBP project was to determine if nursing education and 
implementation of a revised Tdap postpartum policy that included a patient education 
component and standardization of vaccine delivery affected the Tdap vaccine acceptance rate  
among postpartum women. To assess the effectiveness of the nursing education and revised 
Tdap policy, the vaccine acceptance rate of postpartum mothers in the pre intervention group 
was compared to the post intervention group.  
Sample Characteristics 
 Pre intervention group characteristics. The pre intervention group data were 
compiled from 126 medical records. The sample consisted of postpartum patients, ages 16-37 
years who delivered on the OB unit from March 2012 through May 2012. The mean age was 
26.39 years (SD 5.07). The mean length of stay was 2.67 days (SD .989). Of the group, 78.6% 
(n = 99) were Caucasian, 14.3 % (n = 18) were African American, 3.9% (n = 5) were Hispanic, 
0.8% (n = 1) were non-Hispanic, and 2.4% (n = 3) did not answer. The majority of patients 
(51.6%, n = 65), had commercial insurance, 44.4% (n = 56) had Medicaid, 1.6% (n = 2) had 
Medicare, and 2.4% (n = 3) had no insurance.  The pre intervention group consisted of 42.1% 
(n = 53) first time mothers and 57.9% (n = 73) multiparas.  Of the group, 69% (n = 87) had 
vaginal births and 31% (n = 39) had cesarean sections. These findings can be seen on Tables 
4.1 and 4.2.   
 Post intervention group characteristics. The post intervention group data were 
compiled from of 109 medical records. The sample consisted of postpartum patients ages 17-
43 years who delivered on the OB unit from October 2012 through December 2012. The mean 
age was 26.50 (SD 5.54). The mean length of stay was 2.58 days (SD .852). These findings 
can be found on Table 4.1. Just under 78 (n = 85) of the group were Caucasian, 11% (n =  
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Table 4.1 
Age and LOS 
                                             
                                            Pre                Post 
 
t 
 
df 
 
 p value Variable M (SD)    M (SD) 
      
Age 
 
26.39 (5.07) 26.50 (5.54) -.167 233 .867 
             LOS 2.67 (.989) 2.58 (.852)  .730       233      .466 
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Table 4.2 
Demographics of Sample  
                                                       
                                              Pre                Post              Total            X2            df            p   
                                             n (%)              n (%)            n (%) 
 
   
Race                                                                                                   2.88           4            .577 
        Caucasian                   99 (78.6)       85 (77.9)  184 (78.3) 
         African American 18 (14.3) 12 (11) 30 (12.8)    
         Hispanic 5 (3.9) 7 (6.4) 12 (5.1)    
         Non-hispanic 1 (0.8) 0 (0) 1 (0.4)    
         Not Answered 3 (2.4) 5 (4.6) 8 (3.4)    
Insurance    5.122 4 .275 
        Commercial 65 (51.6) 63 (57.8) 128 (54.5)    
        Medicaid 56 (44.4) 45 (41.3) 101 (43)    
        Medicare 2 (1.6) 0 (0) 2 (0.9)    
        None 3 (2.4) 1 (0.8) 4 (1.8)    
Parity    .303 1 .582 
        Primpara 53 (42.1) 42 (38.5) 95 (40.4)    
        Multipara 73 (57.9) 67 (61.5) 140 (59.6)    
Delivery    .537 1 .464 
         Vaginal  87 (69) 80 (73.4) 167 (71.1)    
         C-section 39 (31) 29 (26.6) 68 (28.9)    
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12) were African American, 6.4% (n = 7) were Hispanic, none identified themselves as non-
Hispanic, and 4.6% (n = 5) did not answer their ethnicity. The majority of patients had 
commercial insurance (57.8%, n = 63), 41.3% (n = 45) had Medicaid, none had Medicare, and 
0.8% (n = 1) had no insurance. Of the post intervention group, 38.5% (n = 42) were first time 
mothers, while 61.5% (n = 67) were multiparas. Of the group, 73.4% (n = 80) had vaginal births 
and 26.6% (n = 29) had cesarean sections. These findings can be found on table 4.1.  
Group comparison. Pre and post intervention group characteristics were compared 
using chi-square and t-test analyses. No significant differences between groups were noted for 
race (X2(4) = 2.88, p = .577), insurance (X2(4) = 5.122, p = .275), parity (X2(1) = .303, p =.582) 
or delivery (X2(1) = .537, p =.464). Results can be found on Table 4.2. Independent sample t-
tests were calculated to examine the variables of age (t(233) = -.167, p > .05) and LOS 
(t(233)= .730, p > .05) and no significant differences between groups were identified (see Table 
4.1).The mean LOS for pre intervention group (M = 2.67, SD .989) was not significantly 
different from the mean LOS for the post intervention group (M = 2.58, SD.852). The mean age 
for pre intervention group (M = 26.39, SD 5.07) was not significantly different from the mean 
age post intervention group (M = 26.5, SD 5.54).  
Changes in Outcomes 
Vaccine acceptance. To answer the PICOT question “In postpartum mothers, what is 
the effect of nursing education and implementation of a revised Tdap postpartum policy that 
includes a patient education component and standardization of vaccine delivery on the Tdap 
vaccine acceptance rate over a three month period” a chi-square test for independence was 
performed. There was a significant difference in Tdap vaccine acceptance between   
postpartum mothers in the pre group as compared to the post group. The pre group 
acceptance rate was 11.1% (n = 14). The post group acceptance rate was 65.1% (n = 71). The 
percentage of acceptance can be found in Figure 4.1. Chi square of independence analysis  
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Figure 4.1 Vaccine Acceptance  
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revealed a significant difference (X2 (1) = 68.93, p =.000). Mothers who received the education 
during admission accepted the vaccine significantly more than mothers prior to implementation 
of the EBP project. The chi square analysis can be found on Table 4.3.  
Vaccine documentation.  As displayed in table 4.4, chi square analysis revealed a 
significant difference in the number of patients that had Tdap education documented by nurses 
(X2 (1) = 41.280, p = .000). None of the mothers in the pre intervention group had vaccine 
education documented by the nurses as compared to the post group where 13.2% (n = 31) of 
the mothers had the education documented.  . 
Secondary outcomes 
To determine if there were relationships between the variables of race, insurance, 
parity, and delivery method with Tdap vaccine acceptance, phi coefficients were calculated. 
Weak correlations that were not significant were found between race and vaccine acceptance 
(ɸ = .111, p = .577), insurance and vaccine acceptance (ɸ = .148, p = .275), parity and vaccine 
acceptance (ɸ = .036, p = .582), and delivery method and vaccine acceptance (ɸ = -.048, p = 
.464). Phi coefficients are displayed in table 4.5. To determine if age or length of stay were 
related to vaccine acceptance , point biserial correlations were performed. There was no 
relationship between patient age and vaccine acceptance (rpb = -.016, p = .809) or LOS and 
vaccine acceptance (rpb = .003, p = .963). Point biserial correlations are displayed in Table 4.6. 
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Table 4.3  
Vaccine Acceptance 
  
Pre 
n (%) 
 
Post 
n (%) 
 
X2 
 
df 
 
p 
 
 
 
Vaccine acceptance 
  
16 (11.1) 
 
 
71 (65.1) 
 
68.93* 
 
 
1 
 
 .000 
*p < .05 
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Table 4.4 
Education Documentation  
 
       Pre                Post              Total            X2            df            p   
                                                 n (%)              n (%)            N  
 
            
        235 
 
 41.280* 
       
     1         .000 
 
        Documentation 0 (0) 31 (28.4)     
        No Documentation 126 (100) 78 (71.6)                        
*p < .05 
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Table 4.5 
 
Phi Coefficients for Demographic Characteristics and Vaccine Acceptance 
 
                 
 Demographic 
 Characteristics              ɸ               p value 
 
                    
Race                    .111               .577       
Insurance            .148                 .275       
Parity                   .036                         .582      
Delivery              -.048       .464      
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Table 4.6 
 
Point Biserial Correlations for Demographic Characteristics and Vaccine Acceptance 
 
                                                       
 Demographic 
Characteristic                rpb               p value  
                    
   
Age                          -.016                .809 
  
LOS                               .003                .963 
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Table 4.7 
 
Point Biserial Age and LOS 
 
                                                       
                 rpb               p value  
                    
   
Age    -.016                .809 
  
LOS         .003                .963 
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CHAPTER  5 
DISCUSSION 
The purpose of an EBP is to answer a clinical question, while the goal is to determine 
information (Schmidt, 2012, p.283). The purpose of this EBP project was to determine if 
nursing education and implementation of a revised Tdap postpartum policy, that included a 
patient education component and standardization of vaccine delivery affected the Tdap vaccine 
acceptance rate among postpartum women.  
Explanation of Findings  
 Implementation of a revised Tdap policy significantly increased the acceptance of Tdap 
vaccines among postpartum women. The overall Tdap vaccine acceptance prior to 
implementation was 11.1%. After implementation, vaccine acceptance increased to 65.1%.  
One of the largest contributors to increasing the vaccine acceptance rate among 
postpartum mothers was education of the nurses. The nurses did not realize the risk of 
pertussis transmission from mother to baby or how critically ill an infant could become when 
infected with pertussis. Education of the nurses reinforced the importance of educating the 
patients about the Tdap vaccine and helped the nurses understand how they could influence a 
positive outcome. This finding is consistent with Jackson (2008) who also showed that 
educating providers increases vaccinations of adults and decreases infant pertussis cases.  
 Not only did educating the nurses about the vaccine increase vaccine acceptance, but 
educating the mothers also facilitated acceptance of Tdap vaccine among postpartum mothers. 
When the mothers were educated about pertussis prevention, they were more likely to accept 
the vaccine. In a non-experimental descriptive study, Cheng et al. (2010) aimed to determine 
what factors influence postpartum mothers to receive the Tdap vaccine. Researchers found 
relying on personal recollection of Tetanus Diptheria (Td), when their last Td vaccine was, 
cause less mothers to receive the vaccine. Those who declined the Tdap vaccine thought 
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themselves and their babies were at low risk of getting pertussis, thus Cheng et al. (2010) 
concluded to help increase the acceptance of the vaccine, women of childbearing age should 
be educated on the risk of infants contracting pertussis and on ways to prevent the disease. 
Once the nurses were reeducated on the importance of the vaccine, they were then able to 
educate the mothers. For three months prior to educating the nurses, the acceptance of Tdap 
vaccine among postpartum mothers was only 11.1%, the three month period after education 
reflected an acceptance of 65.1%.  
In addition to education about the Tdap vaccine, the nurses were educated about the 
importance of documenting Tdap vaccine education of the mothers. The nurses used the Tdap 
VIS form as an educational handout. This form was developed by the CDC to educate people 
about specific vaccines. Documentation of vaccine education given was a struggle for the 
nurses at first. During the initial education sessions, documentation of the vaccine was 
addressed broadly. Documentation was not addressed in detail because the nurses had been 
previously documenting other vaccine education in the EMR. The documentation for all nursing 
education in the EMR is very similar, whether it is about a vaccine, procedure performed, or 
medication. The documentation for the nursing education in the EMR has education sets built 
in for the nurses to use as reminders and guidance for the education. Therefore it was 
assumed the nurses already knew how to document education. After implementation of the 
project, it was apparent that some nurses did not know how to properly document the vaccine 
education in the EMR. 
 During the first month of implementation, only four (11.8%) charts had vaccine 
education documented. A plan was then formulated to address the lack of documentation.  The 
unit manager sent out an e-mail reminding the nurses of the Tdap documentation procedure 
which included how and where to document the information. During the second month, 13 
(31.7%) charts included proper documentation of the vaccine. Halfway through the second 
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month, another e-mail reminder was sent out. After the second month of low education 
documentation, an intervention holding each nurse accountable for documentation was 
implemented. Patient charts that did not have the properly documented vaccine education were 
reported to the unit manager. The unit manager held each nurse accountable for his or her 
actions by addressing them individually, instead of addressing the entire group.  According to 
Gabel (2001), it is helpful to speak with and explain to individuals or small groups within the 
organization about specific issues and the decisions made as it relates to them personally, 
instead of large groups or issues they cannot relate to personally. During the third month, 15 
(44.8%) charts had proper vaccine education documentation. Month to month comparison of 
vaccine education documentation can be seen in Figure 5.1. Overall, holding each nurse 
accountable and addressing each one individually helped increase the documentation of 
vaccine education.  
HBM Theoretical Framework 
The HBM is one of the most commonly used conceptual frameworks for health 
promotion and health education (Hayden, 2009). Both health promotion and health education 
are key components for vaccine acceptance among postpartum mothers. The HBM model 
worked well as a guide and framework for this EBP project. The HBM attributes health behavior 
changes to the initiation of readiness for action. The nurses on the OB unit helped prepare the 
postpartum mothers for this action to receive the Tdap vaccine.  
Seriousness. In this EBP project, the nurses helped the mothers understand the 
severity of pertussis. It was critical to the project not only to educate the mothers, but to 
educate the nurses about the severity of pertussis. In the training sessions, nurses were 
shocked to discover the severity of pertussis outcomes in infants younger than 1 year of age. 
Educating nurses about the dire consequences of pertussis motivated them to educate the  
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Figure 5.1 Documentation of Vaccine Education
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mothers and fathers and increased mothers’ acceptance of the vaccine. Roden (2004) also 
found that nurses can facilitate health promotion using the HBM model. In their study they also 
showed there is a need for nurses and their ability to help with health promotion practice.  The 
study concluded that families from lower socioeconomic groups were less able to receive  
health promotion and education from nurses that those from higher socioeconomic status. If 
the nurses were able to provide health promotion and illness prevention to all socioeconomic 
groups, parents would put more priority in activities that would improve children’s health 
(Roden, 2004). 
Susceptibility. Rosenstock et al. (1974) showed that one’s likelihood to engage in a 
preventative health behavior depends not only on severity, but also susceptibility. A second 
author Carolyn (2011) performed a study to see if using patient education based on HBM 
would increase the likelihood of patients adopting a recommendation to wear graduated elastic 
compression stockings (GECS) for prevention of post-thrombotic syndrome (PTS).  
Researchers found that educating the patients about wearing stockings to reduce the risk of 
DVT increased the likelihood of patients wearing stockings. When the nurse gave each mother 
admitted to the unit education on the vaccine, mothers learned how susceptible they were to 
getting the disease, and passing it onto their infant. Once the mothers understood how easy it 
was to pass pertussis to their newborn child, without even knowing they have the disease, it 
helped to increase the mother’s acceptance of the vaccine.  
Perceived benefits. By educating postpartum mothers admitted to the unit about the 
susceptibility and seriousness of pertussis, the nurses helped the mothers understand the 
perceived benefits of the vaccine. Roden (2004) demonstrated that each mother must 
understand and perceive the vaccine will offer a positive benefit. Each mother was able to 
understand the positive benefit of the vaccine, which impacted the vaccine acceptance  among 
postpartum mothers.  
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 Perceived barriers. For the mothers to accept the vaccine, it was important they 
understood that the benefits of receiving the vaccine outweighed the risks. They also had to 
overcome barriers that could stop them from receiving the vaccine. Barriers are affected by 
three different key concepts (a) variables, (b) action cues, and (c) self-efficiency (Glanz, Rimer, 
& Viswanat, 2008).  
Each perception can be modified by different variables and can influence personal 
perceptions and thoughts. Variables that could have influenced vaccine acceptance among 
postpartum mothers included age, race, LOS, parity, type of delivery, and insurance. 
Correlational analysis determined that there was no relationship between any of these 
variables and the acceptance of the Tdap vaccine among postpartum mothers.  
In previous research studies using the HBM model, actions cues were utilized as 
reminders (i.e., poster or pictures) for patients. In this EBP project, the action cues were 
directed at the nurses instead of the patients. Signs in the nursing station, medication room, 
and break room were action cues reminding nurses to offer the vaccine. Other action cues 
aimed at nurses were email reminders about the vaccine and importance of vaccine education 
documentation. The email reminders increased the vaccine education documentation by the 
nurses. The signs also prompted the nurses to offer the vaccine to their patients. Action cues 
were also used with the patients, one on one patient education about the vaccine, and an 
educational handout. 
The third and final key component of the HBM model is self-efficiency. Self-efficiency 
was not addressed in this EBP project. No intervention used during implementation of the 
project focused on self-efficiency. The project implementation did not require the mothers to 
make long-term changes, nor require them to make action changes continuously, which are 
key components to self-efficiency.  
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Some researchers have identified the main weakness of the HBM as inconsistency in 
predicting behaviors (National Institute for Health and Clinical Excellence, 2007). Most of the 
research on the HBM focuses directly on the four perceptions of the model and results 
regarding the ability of the perceptions to predict behavior are not always consistent. Lack of 
research on specific components of the model has been noted by researchers (Eisen, Zellman, 
& MacAlister, 1992; Roden, 2004). A limitation of using the HBM model to guide this EBP 
project was the lack of details provided by previous researchers. Typically authors described 
the model and how they used it, but authors failed to discuss research findings related to the 
HBM.  
Overall the HBM model worked well for the EBP project. The model allows for 
successful implementation of health promotion and education. The nurses were an important 
component in promoting the health of each mother and in turn the health of the infants. The 
nurses providing education to the mothers promoted the health and wellbeing of not only the 
mother, but also the baby. The nurses successfully used the seriousness of the disease to help 
motivate the postpartum mother to receive the vaccine.  They addressed the susceptibility 
component of the HBM by ensuring the mothers realized their susceptibility in contracting the 
disease and transmitting it to their infant. Once the mothers understood how easy it was to 
infect their newborn, mothers elected to accept the vaccine. The nurses also successfully 
helped the mother realize the benefits of the vaccine and overcome barriers to vaccine 
acceptance. The HBM model was a great fit for the EBP project. It allowed the nurses to 
increase the acceptance rate among postpartum mothers by using each component of the 
model.   
JHNEBPM Model 
The JHNEBPM uses the three stages of the PET process to translate evidence into 
practice, (a) practice question, (b) evidence, and (c) translation. The EBP project began with 
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developing a practice question. The practice question developed was, “insert question here.” 
Stiller (2011) identified that pertussis is being unknowingly transmitted from close family 
members to infants. ACIP strongly recommends the use of pertussis vaccine in postpartum 
mothers to decrease the transmission of pertussis to infants (Clark et al., 2006). The second 
stage of the process, evidence, consisted of conducting a systematic review of the literature. 
During the third stage, translation, administering the Tdap vaccine to postpartum women on the 
OB unit was determined feasible and the main outcome to monitor was identified, Tdap vaccine 
acceptance rate of postpartum women.  
“Initial response to JHNEBP model has been positive by researchers, but since its 
inception in 2001, minimal research on the model has been conducted (Otten, 2008; Crawford, 
2009). The JHNEBPM worked well for this EBP project. The framework guided the actual 
process of the EBP project. It allowed for the clinical question to be translated into practice. 
The model facilitated the development of the practice question. The evidence stage was very 
useful in appraising the literature. The tools associated with the model addressed the level and 
quality of each piece of evidence. Successful synthesis of the evidence was performed and 
practice recommendations where developed for the EBP project. The overall use of the 
JHNEBPM was a great fit for this EBP project; it facilitated the translation of evidence into 
practice.  
Strengths of the EBP project 
 The willingness of the nurses to participate, the support from management, and a 
strong project leader were major strengths of the project. The nurses were not only willing to 
help make a change, but they were motivated to implement the change. Education about the 
effects of pertussis on the infant motivated the nurses to implement the EBP project. The 
motivation process begins when an individual notices a deficit within themselves (Burns, 
Bradley, & Weiner, 2012).  The nurses were motivated to implement the change by facilitating 
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patient education and thus impacting Tdap vaccine acceptance. When the nurses were willing 
to facilitate the change, it was much easier for that change to occur. The nurses are 
stakeholders in the organization. A stakeholder is a person or group of people who are affected 
by your ideas and for change in an in any organization to occur, stakeholders must be vested 
in that change (Burns, Bradley, & Weiner, 2012, p.167). In a study done by Roussel et al. 
(2012) to determine how nurses (stakeholders) commit to effecting change. Researchers found 
that stakeholder’s are more willing to adapt and implement change when they are able to see 
the change and understand the change that is occurring.   
 Project support from the unit manager and the Chief Nursing Officer (CNO) also 
influenced the nursing staff and facilitated the project. According to Burns et al. (2012) studies 
need the support of administrative and clinical leadership for the success of organizational 
change. Nurse leaders have to face the challenges of taking their team through uncertainty 
with change (Salmela, Eriksson, & Fagerstrom, 2012). In a qualitative study by Salmela, 
Eriksson, and Fagerstrom (2012), researchers aimed to describe nurse leaders’ perceptions of 
their role in change. They showed nurse leaders play important roles in change by directing, 
guiding, motivating, supporting, and communicating with their staff (Salmela et al., 2012). The 
unit manager was a key player to the success of this project. The manager helped guide, 
educate, remind, and implement the policy change. She was the key person that held the 
nurses accountable for their actions. Change is much easier to implement when management 
is prepared, supportive, and communicates with their staff during change.   
 Evidence has shown nurses may have difficulty implementing new knowledge into 
clinical practice (Buonocore, 2004). APNs have advanced clinical training and advanced 
knowledge of the change process, which allows them to be perfect agents of change 
(Buonocore, 2004). The APN guided the project through all phases, the evidence search and 
appraisal, Tdap policy revision, and educational training of nurses. The APN established 
62 
 
 
 
 
credibility with the nursing staff by providing a revised policy based on the best evidence and 
an organized plan for implementation. Having expertise allows for the APN to have the power 
to be a great change agent. Change is needed within an organization to improve patient 
outcomes and improve patient care (Buonocore, 2004).   
Weakness of EBP  
One limitation of this EBP project was the lack of knowledge of EBP among nurses. 
When the nurses were in the education sessions before implementation of the project, they 
appeared very uncomfortable discussing EBP. Once the project was fully explained and the 
nurses better understood the project, they were more at ease. Several barriers have been 
identified which prevent the use of EBP among nurses. Two of the barriers are time constraints 
and lack of confidence with research utilization skill (Drenning, 2006). In the training sessions, 
there was a wide range of experience among nursing staff. Some of the staff had numerous 
years and some were newer graduates. One weakness of veteran nurses is the lack of 
education of EBP. When someone is unfamiliar with the topic at hand, they usually are more 
uncomfortable accepting it and allowing for change. The various levels of education and 
experience of nurses within a unit can be a weakness. A study done by Estabrooks et al. 
(2005) showed hospitals that had a higher ratio of baccalaureate degree prepared nurses and 
a richer skill mix had a lower 30 day mortality rate. Therefore, the higher the education and skill 
levels of the nurses, the better the outcomes for the patients.  
Another weakness for the EBP project was the organizational structure of the system 
where the EBP project was performed. There are a number of hospital facilities within the 
organizational system where the EBP project was implemented. Approval of the EBP project 
required, not only hospital approval, but organizational approval. Communicating project ideas 
at times was difficult. The different levels of the organization did not always agree with each 
other and thus, the approval process was time consuming.  
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One of the main problems with multiple organizational levels is potential 
miscommunication between the various levels. In the initial phases of approval to implement 
the EBP project, the unit manager wanted to implement a written consent, but when attempting 
to gain organizational approval, it was discovered that the organization, as a whole, was not 
supportive of implementing consents for vaccines. This was a lack of communication between 
the upper administration and the unit manager. All communication was written as opposed to 
face to face meetings. When organizations do not have good communication within all layers of 
the organization, then miscommunication occurs and problems arise.  
Implications for the Future 
 
 Change is always a struggle within organizations.  It is important that advance practice 
nurses and staff nurses work together to support change within an organization. The burden of 
EBP implementation should not fall on one person or discipline, but should be shared with 
nurses involved in direct patient care, practitioners, the unit manager, and those in clinical 
research (Drenning, 2006). It is imperative that both nurses and APNs work together to ensure 
more patients receive Tdap vaccines by educating patients both on OB units and in doctors’ 
offices.  APNs can guide nurses on EBP practices and help increase positive outcomes for 
patients. Combining the skills of nurses and APNs, can facilitate change in clinical practice to 
improve patient outcomes (Drenning, 2006).  The APN can begin the education process with  
the patient during an office or outpatient visit, and the nurse can reinforce the education once 
the patient is admitted to the hospital. APNs can continue to teach the patients with the nurses 
within the hospital setting as well. The nurse can also refer those patients that need extra 
education to the APN in the inpatient setting.   
Overall, further research is needed to determine best practice guidelines for increasing 
Tdap acceptance among postpartum mothers. More research should be conducted to 
determine the efficacy of Tdap vaccine administration during pregnancy. Currently, the 
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recommendations are for the vaccine to be given before pregnancy occurs, immediately 
postpartum, or during pregnancy in cases when benefits outweigh risks. There currently is 
ongoing research to determine exactly when the Tdap vaccine should be given during 
pregnancy. Methods of Tdap vaccine implementation within hospitals is another area needing 
further research. There are no recommendations on the best way to implement these 
programs. Researchers should compare implementation methods of hospital-based vaccine 
programs and evaluate which program results in the best outcomes for patients. The original 
hospital Tdap policy that was implemented on the OB unit did not focus on educating the 
nursing staff prior to implementation and the policy was not followed. Implementation of the 
revised policy focused on educating the nurses and staff of the OB unit on the new policy 
before implementation, which showed a significant increase in the nurses administering the 
vaccine immediately postpartum.  Educating the postpartum mothers on the vaccine will 
increase the acceptance rate of Tdap vaccines and in turn decrease the transmission of 
pertussis to infants. It is imperative for hospitals, doctors’ offices, and nursing schools to 
educate all nurses, APNs, and physicians on the importance of vaccination against pertussis.  
Conclusion 
 APNs play a key role in implementing EBP within an organization.  Not all evidence will 
work successfully in every setting. Determining translation of the evidence and the support of 
the organization will help allow for change. Increasing the acceptance rate of Tdap vaccine 
among postpartum mothers was supported by educating the nurses before implementing the 
revised Tdap policy and educating the patients on the Tdap vaccine. To have a successful 
change in an organization, the organization needs strong leadership, change agents, 
organizational support, and willingness of staff to allow for change.  
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ACRONYM LIST 
ACIP: According to the Advisory Committee on Immunization Practices  
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JHNEBPM : John Hopkins Nursing Evidence-Based Practice Model  
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Td: Tetanus Diphtheria 
Tdap: Tetanus, Diphtheria and Pertussis 
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Appendix A 
Tdap Policy 
Purpose: To meet the Advisory Committee on Immunization Practices (ACIP) guidelines for 
Tdap vaccinations for postpartum patients. The ACIP is an advisory committee to the Centers 
for Disease Control and Prevention (CDC). 
 
General  Information: 
 
1.0 Upon admission to the unit, Tdap vaccine status will be evaluated on all OB patients. If 
no contraindications exist, the Tdap (Tetanus, diphtheria and pertussis) vaccine will be 
offered to those who have not had the Tdap vaccine in the last 2 years.  
       
     2.0 Contraindications to Tdap include: 
• 2.1 A previous immunization of Tdap within the last two years 
• 2.2 Allergy to components of the vaccine 
 
3.0 All Patients will receive teaching about the vaccine upon admission to the unit.  
 
4.0 The Vaccine Information Sheet (VIS) entitled, “Td or Tdap (tetanus-diptheria or tetanus- 
diphtheria-pertussis) Vaccine: What You Need to Know” will be provided to all patients. 
 
5.0 Tdap dose is 0.5 ml IM and is a onetime dose. 
 
6.0 The vaccine will be taken into the delivery area and administered during the immediate 
postpartum period. 
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Appendix B 
Vaccine Information Sheet 
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Appendix C 
Nurses Information Sheet 
Pertussis  
 
Why is Tdap important? 
 
In 2009, there were more than 16,000 cases of pertussis in infants less than 6 month of age 
(National Network for Immunizations and Information, 2011). 
 
50 out of every 10,000 children less than one who develop pertussis will die from it! 
 
In June 2011 to June 2012 the unit administered 59 vaccines.  
 
What can we do?  
 
We can help stop the spread of pertussis by vaccination. The CDCs “primary goal of pertussis 
outbreak control efforts is to decrease morbidity (amount of disease) and mortality (death) 
among infants; a secondary goal is to decrease morbidity among persons of all ages”.  
 
ACIP recommends administration of Tdap immediately postpartum.  
 
Project implementation 
 
First, educate the patient on the importance of the vaccine and what it is, using the CDC VIS 
upon admission to the OB unit. Document patient teaching and receiving the VIS form in the 
EMR.  
 
Next upon patient going into active labor, take vaccine into patient’s room and administer the 
vaccine as soon as possible postpartum.  
 
Finally, document administration of vaccine in EMR. If patient does not want the vaccine, then 
state why they do not want the vaccine.  
 
 
 
 
 
 
 
 
 
 
